United Kingdom-Chester: Medicinal products used in diabetes – Framework Lead

The current contract for Medicinal products used in diabetes – Framework Lead is projected to end on 22-FEB-20 and may be available for retender. The Supply of Insulin Pump Solutions (including Pumps, Related Consumables, Home Delivery Service and Support).
The Countess of Chester Hospital NHS Foundation Trust (the Trust) and West Cheshire Clinical Commissioning Group (CCG) are seeking to establish a framework agreement for the provision of insulin pump solutions which includes the supply of insulin pumps, consumables, home delivery service and support. The Framework Agreement seeks to establish continuity of quality products and service and best value for money for the whole health economy of West Cheshire.
As a range of insulin pump solutions is required to meet the varying needs of patients with diabetes, the Trust is seeking to establish a multi-supplier framework to ensure that all patient needs can be met.
It is anticipated that no less than 4 and no more than 10 suppliers will be appointed to the framework agreement.
As this is a framework agreement no commitment on any volumes or spend is offered.
The framework agreement term will be 2 years with the option to extend for up to a further 2 years, in 1 year increments.
Common procurement vocabulary (CPV): 33615000, 33615100,